Clinical Trials Logo

Food Allergy in Infants clinical trials

View clinical trials related to Food Allergy in Infants.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT05287074 Enrolling by invitation - Clinical trials for Food Allergy in Children

The Significance of a Timely Food Allergy Diagnosis and Optimal Surveillance of Nutritional Status in Children

Start date: July 1, 2021
Phase:
Study type: Observational

The aim of this study is to gain more knowledge on the nutritional and immunological aspects of allergy to milk and eggs in children.

NCT ID: NCT04955132 Enrolling by invitation - Clinical trials for Food Allergy in Children

Impact of E-learning on Parental Confidence in Managing Food Allergy

Start date: July 1, 2021
Phase: N/A
Study type: Interventional

Education and dietary support are integral in managing food allergy in children. The study aim is to analyze the impact of E-learning on parental confidence in managing their child's food allergy.

NCT ID: NCT04604431 Enrolling by invitation - Clinical trials for Food Allergy in Infants

Intervention to Reduce Early (Peanut) Allergy in Children

iREACH
Start date: November 4, 2020
Phase: N/A
Study type: Interventional

iREACH is a five-year NIH funded study aimed at assessing and improving pediatric clinician adherence to the 2017 NIAID Prevention of Peanut Allergy (PPA) Guidelines. iREACH has been developed as an electronic health record (EHR) integrated Clinical Decision Support (CDS) tool together with educational modules on the PPA guidelines to assist clinicians in implementing the 2017 NIAID PPA Guidelines. A practice-based, two-arm, cluster-randomized clinical trial will evaluate the effectiveness of iREACH in increasing pediatric clinician adherence to the PPA Guidelines and explore the end-goal of reducing peanut allergy incidence by age 2.5 years in the intervention vs control group. This study has the potential to: 1) provide evidence regarding the effectiveness of iREACH in promoting clinical processes and outcomes related to the PPA Guidelines, 2) provide important insight about practice-based implementation of PPA Guidelines by pediatric clinicians, allergists and caregivers, and 3) facilitate rapid, widespread implementation of PPA Guidelines and reduce peanut allergy incidence across the US.